4V.B.Antony,R.Loddenkemper,P.Astoul,et al.Management of malignant pleural effusions[J].Eur Respir J,2001,18:402–419.
5M.H.Uzbeck,F.A.Almeida,M.G.Sarkiss,et al.Management of Malignant Pleural Effusions[J].Adv Ther,2010,27(6):334-347.
6Garofalo A,Valle M,Garcia J,et al.Laparoscopic intraperitoneal hyperthermia chemotherapy for pallimion of debilitating malignant ascites[J].Eur J Surg One,2006,32(6):682-685.
7Knutsen A,Sielaff TD,Greeno E,et al.Staged laparoscopic infusion of hyperthermia intraperitoneal chemotherapy after cytoreductive surgery[J].Gastrointest Surg,2006,10(7):1038-1043.
8Gomez Rubio M,de Cuenca Moron B9Dominguez M.Tumoral markers in liver cirrhosis and hepatocellular carcinma[J].Gastroenterol Hepatol,2005,28(5):308.
9Sari R,Yildirim B,Sevinc A,Bahceci F.The importance of serum and ascites fluid alpha fetoprotein carcinoembryonic antigen CAl 9-9 and CAl 5-3 levels in differential diagnosis of ascitesetiology[J].Hepatogastroenterology,2001,48(42):1616-1621.
10Wang IK,Chuang FR,Lee KF,et al.Tuberculous peritonitis in a haemodialysis patient with elevated serum CA125 and hypocaIcaemia[J].Int I Clin Pract Suppl,2005,(147):56-59.
